ATX 8.96% 6.1¢ amplia therapeutics limited

mpact is the name of the p3 trial that showed adding abraxane to...

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    mpact is the name of the p3 trial that showed adding abraxane to gemcitabine increased median survival over gemcitabine by itself. It’s published. Yes abraxane was approved in pancreatic cancer based on mpact.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
-0.006(8.96%)
Mkt cap ! $16.56M
Open High Low Value Volume
6.5¢ 6.5¢ 5.6¢ $42.68K 709.9K

Buyers (Bids)

No. Vol. Price($)
1 642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 236421 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.